Twice as many patients receiving CR-CBZ discontinued due to adverse events or death compared to those in the LEV group ( @ % vs. @ % ; odds ratio @ , @ % confidence interval -LSB- CI -RSB- @-@ @ , p = @ ) , whereas discontinuation was intermediate for LTG ( @ % ) .